Axcelis Technologies, Inc. Stock News

Q3 2026 Highlights: Revenue of $237.8 million GAAP Gross Margin of 41.0%, and Non-GAAP Gross Margin of 41.2% GAAP Operating Margin of 11.5% and Non-GAAP Operating Margin of 16.6% GAAP Diluted Earnings Per Share of $1.21, and Non-GAAP Diluted Earnings Per Share of $1.26 BEVERLY, Mass., Nov. 5, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for th...

Merger now expected to close by the end of the first quarter of 2027 BEVERLY, Mass., and PLAINVIEW, N.Y.

BEVERLY, Mass., Oct. 27, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced the appointment of Jeroen Delsman as Executive Vice President and Chief Financial Officer effective November 12, 2026.

$35 Million Investment Will Expand Axcelis' Manufacturing Capacity and Enable the Company to Better Serve Customers BEVERLY, Mass., Oct. 20, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced that it will officially break ground on its new ion implantation equipment manufacturi...

BEVERLY, Mass., Sept. 21, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be participating in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026) taking place September 28 - October 2, 2026, at the Pacifico Yokohama North in Japan.

BEVERLY, Mass., Sept. 14, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be a Platinum Sponsor at the International Conference on Ion Implantation and Annealing Technology 2026 (IIT 2026) taking place September 20-24 at the Congress Center Villach in Austria.

BEVERLY, Mass., Sept. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced plans to invest $35 million in its global manufacturing infrastructure through the construction of a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea.